Invention Grant
- Patent Title: Bruton's tyrosine kinase inhibitors
-
Application No.: US16420140Application Date: 2019-05-22
-
Publication No.: US10793566B2Publication Date: 2020-10-06
- Inventor: Xibin Liao , Jia Li , Zhijian Lu , Yubo Zhou , Anhui Gao
- Applicant: Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. , Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Applicant Address: CN Zibo CN Shanghai
- Assignee: ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO. LTD.,SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Current Assignee: ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO. LTD.,SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Current Assignee Address: CN Zibo CN Shanghai
- Agency: SZDC Law PC
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D403/04 ; C07D401/04 ; A61P35/00 ; A61K31/52
Abstract:
Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I):
Public/Granted literature
- US20190276453A1 BRUTON'S TYROSINE KINASE INHIBITORS Public/Granted day:2019-09-12
Information query
